UBS AM’s Aimmune Therapeutics, Inc. AIMT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-38,944
| Closed | -$1.34M | – | 2623 |
|
|
2020
Q3 | $1.34M | Sell |
38,944
-462
| -1% | -$15.9K | ﹤0.01% | 1718 |
|
|
2020
Q2 | $658K | Buy |
39,406
+630
| +2% | +$10.5K | ﹤0.01% | 1994 |
|
|
2020
Q1 | $559K | Sell |
38,776
-1,944
| -5% | -$28K | ﹤0.01% | 1936 |
|
|
2019
Q4 | $1.36M | Sell |
40,720
-1,167
| -3% | -$39.1K | ﹤0.01% | 1762 |
|
|
2019
Q3 | $877K | Buy |
41,887
+843
| +2% | +$17.7K | ﹤0.01% | 2021 |
|
|
2019
Q2 | $855K | Buy |
41,044
+16,672
| +68% | +$347K | ﹤0.01% | 1961 |
|
|
2019
Q1 | $545K | Buy |
24,372
+3,472
| +17% | +$77.6K | ﹤0.01% | 2077 |
|
|
2018
Q4 | $500K | Hold |
20,900
| – | – | ﹤0.01% | 1996 |
|
|
2018
Q3 | $570K | Hold |
20,900
| – | – | ﹤0.01% | 2033 |
|
|
2018
Q2 | $562K | Sell |
20,900
-1,447
| -6% | -$38.9K | ﹤0.01% | 2050 |
|
|
2018
Q1 | $711K | Buy |
22,347
+13,447
| +151% | +$428K | ﹤0.01% | 1888 |
|
|
2017
Q4 | $337K | Sell |
8,900
-282,123
| -97% | -$10.7M | ﹤0.01% | 2086 |
|
|
2017
Q3 | $7.21M | Buy |
+291,023
| New | +$7.21M | 0.01% | 974 |
|